 |
 |
|
|||||
Transplant Statistics: Annual Report
APPENDIX C
The OPTN Organization
UNOS AND THE OPTN ORGANIZATION
To conform to OPTN contract requirements, UNOS elects annually a new Board of Directors, which comprises representatives from groups of OPTN members and the public at large. As mandated by the Health Resources and Services Administration (HRSA), the Board is composed of members representing each of the OPTN regions (regional councillors, one per region), and representatives from the following OPTN categories: Patient and Donor Families, Thoracic Organ Transplantation, Histocompatibility Laboratories, Organ Procurement Organizations, Transplant Coordinators, Voluntary Health Organizations, Medical/Scientific Organizations, Minority Transplantation, and General Public Members. Also included on the Board are members of the transplant community serving as President, Immediate Past President, Vice President/President Elect, Vice President of Patient and Donor Affairs, Treasurer, and Secretary. The composition of the 2001-2002 Board is shown in Table C-1.
UNOS also has an established internal administrative organization with an Executive Director, two Assistant Executive Directors, and internal departments including: a 24-hour Organ Center, Clinical Data Systems, Communications, Finance, Human Resources, Information Technology, Membership, Policy, Policy Compliance, Professional Services, Research, and Travel and Conference Planning.
As part of its duties in carrying out the functions of the OPTN, UNOS has established membership criteria and medical criteria for allocating organs and, in many instances, has provided an opportunity for members of the public and other interested persons to comment with respect to these criteria. UNOS admits to the OPTN and retains as members all organ procurement organizations, hospitals, and histocompatibility laboratories that apply for membership and agree to comply with OPTN rules and requirements. Pursuant to its contract with HRSA, the OPTN Board of Directors has adopted by-laws and policies developed with the aid of organ transplant professionals and patient representatives. These by-laws and policies have been submitted to the Secretary of HHS for review and are considered voluntary guidance to OPTN members until approved as OPTN rules and requirements by the Secretary of HHS. UNOS is responsible for keeping these by-laws and policies up-to-date and for monitoring compliance by OPTN members.
OPTN members fall into one of two categories, institutional members and public members. Institutional members include transplant centers, OPOs, histocompatibility laboratories, and consortia. Public members include the following: 1) private, non-profit voluntary health organizations which promote organ donation nationwide or which serve the interests of transplant patients and their families; 2) private, non-profit medical or scientific membership organizations with involvement in transplantation; and 3) individuals representing the general public. General public members commonly represent such fields as theology, ethics, health care financing, social and behavioral sciences, patients, patient advocates, and donor families. The composition of the OPTN membership on July 1, 2001, is displayed in Table C-2.
OPTN member transplant programs are enumerated according to type in Table C-3.
For administrative purposes, the country is divided into 11 geographic regions. Each region is assigned a UNOS staff administrator to assist in coordinating regional activities. Additionally, each region is represented on the Board of Directors and on each of the OPTN's permanent standing committees. Figure C-1 on the following page depicts the current OPTN regions.
It is through committees, constituted to ensure geographic, individual, and organizational representation, that policies are formulated for approval by the OPTN Board of Directors. OPTN committees may develop policy recommendations on their own initiative or upon recommendation by the Board. The Board accepts policy proposals on all issues affecting transplantation. Each proposal is accompanied by a description of the underlying rationale and, where applicable, a summary of medical, ethical, and scientific evidence upon which the proposed policy is based. The Board may approve, disapprove, or amend the proposed policy statement or return it to committee for further consideration.
OPTN members and the public at large are given an opportunity to contribute to the policy development process. Policy statements developed by committees are distributed to OPTN members and the Federal Government for comment before they are submitted to the Board for approval. They also may be made available to the general public via media coverage and/or public hearings. Following a 45-day public
comment period, the committee reviews and amends the policy as it deems necessary, then submits the amended policy proposal to the Board of Directors for a final vote.
As of July 1, 2001, the OPTN had 15 standing committees per its by-laws, Article VI, and three ad hoc committees. Members are recommended by the regional councillors and/or selected to provide broad expertise for committee activities. Committees receive input from regional subcommittees, the transplant community, and the public. The 2001-2002 OPTN standing and ad hoc committees are listed below. For a description of each committee's charge and scope of activities, visit Members (Committees) at www.optn.org for further details.
1. Communication
2. Data Advisory
3. Ethics
4. Executive
5. Finance
6. Histocompatibility
7. Kidney/Pancreas Organ Transplantation
8. Liver/Intestinal Organ Transplantation
9. Membership and Professional Standards
10. Minority Affairs
11. Organ Availability
12. Organ Procurement Organization
13. Patient Affairs
14. Pediatric Transplantation
15. Thoracic Organ Transplantation
16. Ad Hoc Allocation Modeling Oversight
17. Ad Hoc International Relations
18. Ad Hoc Transplant Administrators
Jeremiah G. Turcotte, M.D., President
University of Michigan Health Systems
Ann Arbor, MI
Clyde F. Barker, M.D., Vice President/President Elect
University of Pennsylvania Hospital
Philadelphia, PA
Charles F. McAfee, FAIA, NOMA, Vice President of Patient and Donor Affairs
Charles F. McAfee FAIA, NOMA, PA and Program Managers
Wichita, KS
Richard J. Rohrer, M.D., Secretary
New England Medical Center
Boston, MA
Thomas M. Beyersdorf, M.B.A., Treasurer
Transplantation Society of Michigan
Ann Arbor, MI
Patricia L. Adams, M.D., Immediate Past President
Wake Forest University School of Medicine
Winston-Salem, NC
Region 1 Jeffrey S. Stoff, M.D.
UMass Memorial Health Care
Worcester, MA
Region 2 Kenneth L. Brayman, M.D., Ph.D.
University of Pennsylvania Hospital
Philadelphia, PA
Region 3 Richard J. Howard, M.D., Ph.D.
University of Florida
Gainesville, FL
Region 4 Victor L. Robards, Jr., M.D.
Urologic Specialists of Oklahoma
Tulsa, OK
Region 5 Robert B. Ettenger, M.D.
UCLA School of Medicine
Los Angeles, CA
Region 6 Michael S. Seely, M.S., R.N., C.P.T.C.
Pacific Northwest Transplant Bank
Portland, OR
Region 7 Russell H. Wiesner, M.D.
Mayo Clinic
Rochester, MN
Region 8 Dean F. Kappel, M.S.W.
Mid-America Transplant Services
St. Louis, MO
Region 9 Lewis W. Teperman, M.D.
New York Univ. School of Medicine
New York, NY
Region 10 Robert M. Merion, M.D.
University of Michigan Health System
Ann Arbor, MI
Region 11 Robert A. Fisher, M.D.
Medical College of Virginia Hospitals
Richmond, VA
Robert S.D. Higgins, M.D.
Medical College of Virginia Hospitals
Richmond, VA
Robert A. Bray, Ph.D.
Emory University Hospital
Atlanta, GA
Dolly B. Tyan, Ph.D. -- ASHI
Cedars-Sinai Medical Center
Los Angeles, CA
Judy M. Graham, R.N., C.S., C.C.R.N., C.P.T.C.
New York Organ Donor Network
New York, NY
Jeffrey S. Mitoff, R.N., B.S.N., C.P.T.C.
Mayo Clinic Hospital
Phoenix, AZ
Susan Gunderson, M.H.A.
LifeSource
St. Paul, MN
Dennis F. Heinrichs, B.S.N., M.B.A., C.P.T.C.
LifeLink Foundation, Inc.
Tampa, FL
Clive O. Callender, M.D.
Howard University Hospital
Washington, DC
Rhoda L. Blicht, M.B.A.
New York Organ Donor Network & American Liver Foundation
Commack, NY
John Davis
National Kidney Foundation
New York, NY
Ronald M. Ferguson, M.D., Ph.D. -- ASTS
Ohio State University Hospital
Columbus, OH
John Lake, M.D. -- AST
Fairview-University Medical Center
Minneapolis, MN
Lynt B. Johnson, M.D.
Georgetown University Medical Center
Washington, DC
C. Wright Pinson, M.D. M.B.A.
Vanderbilt University Medical Center
Nashville, TN
Keenan Behrle, J.D.
Beverly Hills, CA
A. Watson Bell, J.D.
Searcy, AR
Leonard H. Bucklin, B.S.L., J.D.
Tempe, AZ
Hester Taylor Clark, M.Ed.
Jacksonville, FL
Charles F. McAfee, FAIA, NOMA
Wichita, KS
John M. Newmann, Ph.D., M.P.H.
Reston, VA
Paul B. Oldam, B.S.S.
Elm Grove, WI
Esther Padilla M.S.W.
Fresno, CA
Donald J. Rager, Jr.
Temecula, CA
Margaret J. Schaeffer, R.N., C.P.T.C.
Richmond, VA
Lawrence L. Schkade, Ph.D., C.C.P., C.S.P.
Arlington, TX
ASHI -- American Society for Histocompatibility and Immunogenetics
AST -- American Society of Transplantation
ASTS -- American Society of Transplant Surgeons
Patricia L. Adams, M.D., President
Wake Forest University School of Medicine
Winston-Salem, NC
Jeremiah G. Turcotte, M.D., Vice President
University of Michigan Health Systems
Ann Arbor, MI
John M. Newmann, Ph.D., MPH, Vice President of Patient and Donor Affairs
Health Policy Research & Analysis, Inc.
Reston, VA
Richard J. Rohrer, M.D., Secretary
New England Medical Center
Boston, MA
Suzanne Lane Conrad, R.N., M.S., CPTC, Treasurer
Iowa Donor Network
Iowa City, IA
William D. Payne, M.D., Immediate Past President
Fairview-University Medical Center
Minneapolis, MN
Region 1 Jeffrey S. Stoff, M.D.
UMass Memorial Health Care
Worcester, MA
Region 2 Baburao Koneru, M.D.
UMDNJ University Hospital
Newark, NJ
Region 3 Thomas G. Peters, M.D.
Jacksonville Transplant Center
Jacksonville, FL
Region 4 Victor L. Robards, Jr., M.D.
Urologic Specialists of Oklahoma
Tulsa, OK
Region 5 Robert B. Ettenger, M.D.
UCLA School of Medicine
Los Angeles, CA
Region 6 Michael S. Seely, M.S., R.N., C.P.T.C.
Pacific Northwest Transplant Bank
Portland, OR
Region 7 Raymond Pollak, M.D.
University of Illinois at Chicago
Chicago, IL
Region 8 James W. Springer, B.A., C.P.T.C.
Littleton, CO
Region 9 Lewis W. Teperman, M.D.
New York Univ. School of Medicine
New York, NY
Region 10 James A. Schulak, M.D.
University Hospital of Cleveland
Cleveland, OH
Region 11 A. Osama Gaber, M.D.
University of Tennessee Med. Group
Memphis, TN
Robert S.D. Higgins, M.D.
Medical College of Virginia Hospitals
Richmond, VA
Dolly B. Tyan, Ph.D. -- ASHI
Cedars-Sinai Medical Center
Los Angeles, CA
Bruce Nicely, R.N., C.P.T.C.
LifeNet Transplant Services
Virginia Beach, VA
Jeffrey S. Mitoff, R.N., B.S.N., C.P.T.C.
Mayo Clinic Hospital
Phoenix, AZ
Susan Gunderson, M.H.A.
LifeSource
St. Paul, MN
Michael S. Seely, M.S., C.P.T.C.
Pacific Northwest Transplant Bank
Portland, OR
Cass Franklin, M.D.
Iowa Methodist Medical Center
Des Moines, IA
Rhoda L. Blicht, M.B.A.
New York Organ Donor network & American Liver Foundation
Commack, NY
John Davis
National Kidney Foundation
New York, NY
Ronald M. Ferguson, M.D., Ph.D. -- ASTS
Ohio State University Hospital
Columbus, OH
Served July 2000 to November 2000
John F. Neylan, M.D. -- AST
Emory University Hospital
Atlanta, GA
Served November 2000 to June 2001
John Lake, M.D. -- AST
Fairview-University Medical Center
Minneapolis, MN
Lynt B. Johnson, M.D.
Georgetown University Medical Center
Washington, DC
C. Wright Pinson, M.D. MBA
Vanderbilt University Medical Center
Nashville, TN
Keenan Behrle, J.D.
Beverly Hills, CA
A. Watson Bell, J.D.
Searcy, AR
Leonard H. Bucklin, J.D.
Tempe, AZ
Hester Taylor Clark, M.Ed.
Jacksonville, FL
Charles F. McAfee, FAIA, NOMA
Wichita, KS
John M. Newmann, Ph.D., M.P.H.
Reston, VA
Paul B. Oldam, B.S.S.
Elm Grove, WI
Donald J. Rager, Jr.
Temecula, CA
Margaret J. Schaeffer, R.N., C.P.T.C.
Richmond, VA
Lawrence L. Schkade, Ph.D., C.C.P., C.S.P.
Arlington, TX
ASHI -- American Society for Histocompatibility and Immunogenetics
AST -- American Society of Transplantation
ASTS -- American Society of Transplant Surgeons
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.